On October 10, 2024, Pfizer Inc. announced the appointment of Mortimer J. Buckley to its Board of Directors, effective immediately. Buckley, with a distinguished career including serving as Chairman and CEO of Vanguard until his retirement in 2024, brings extensive experience in global investment management, financial markets, and operations. His previous roles at Vanguard included Chief Investment Officer and Chief Information Officer. Buckley's election to the Board was part of a search initiated in May 2024. He will also join the Governance & Sustainability Committee and the Audit Committee. Pfizer's Board now comprises 14 directors, 13 of whom are independent. The company's Chairman and CEO, Albert Bourla, expressed confidence that Buckley's expertise and values will benefit Pfizer and its shareholders. Buckley, honored by the appointment, commended Pfizer's dedication to innovation and patient care. The announcement was made through a press release on October 15, 2024.

On October 10, 2024, Pfizer Inc. announced the appointment of Mortimer J. Buckley to its Board of Directors, effective immediately. Buckley, with a distinguished career including serving as Chairman and CEO of Vanguard until his retirement in 2024, brings extensive experience in global investment management, financial markets, and operations. His previous roles at Vanguard included Chief Investment Officer and Chief Information Officer. Buckley's election to the Board was part of a search initiated in May 2024. He will also join the Governance & Sustainability Committee and the Audit Committee. Pfizer's Board now comprises 14 directors, 13 of whom are independent. The company's Chairman and CEO, Albert Bourla, expressed confidence that Buckley's expertise and values will benefit Pfizer and its shareholders. Buckley, honored by the appointment, commended Pfizer's dedication to innovation and patient care. The announcement was made through a press release on October 15, 2024.